Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Oriflame in relation to the groups change of domicile from Luxembourg to Switzerland
Mandate

Vinge advises Oriflame in relation to the groups change of domicile from Luxembourg to Switzerland

May 11, 2015

Vinge advises Oriflame in connection with the process of changing the group’s domicile from Luxembourg to Switzerland. As part of this process, Oriflame Holding AG, a wholly owned Swiss subsidiary of Oriflame Cosmetics S.A., has announced a share-for-share exchange transaction. The shares of Oriflame Holding are intended to be listed on the main market of Nasdaq Stockholm.

Erik Sjöman and Dain Hård Nevonen (partners, capital markets & public M&A) and Sabina Börjesson and Joel Wahlberg advise Oriflame. Mattias Schömer (partner, tax) and Tora Hansjons provide tax advice.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025